Authors:
VANDEMERBEL NC
TINKE AP
OOSTERHUIS B
JONKMAN JHG
BOHLE JF
Citation: Nc. Vandemerbel et al., DETERMINATION OF PILOCARPINE, ISOPILOCARPINE, PILOCARPIC ACID AND ISOPILOCARPIC ACID IN HUMAN PLASMA AND URINE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH TANDEM MASS-SPECTROMETRIC DETECTION, Journal of chromatography B. Biomedical sciences and applications, 708(1-2), 1998, pp. 103-112
Authors:
VANDEMERBEL NC
TINKE AP
VANDONGEN WD
OOSTERHUIS B
JONKMAN JHG
LADURE P
PUOZZO C
Citation: Nc. Vandemerbel et al., VALIDATED METHOD FOR THE DETERMINATION OF IDAZOXAN IN HUMAN PLASMA BYLIQUID-CHROMATOGRAPHY WITH TANDEM MASS-SPECTROMETRIC DETECTION, Journal of chromatography B. Biomedical sciences and applications, 708(1-2), 1998, pp. 113-120
Authors:
HENDRIKS MGC
DOGTEROM P
EBELS JT
OOSTERHUIS B
GEERTSEMA LR
HULOT T
BIANCHETTI G
JONKMAN JHG
Citation: Mgc. Hendriks et al., A STUDY COMPARING BIOPHARMACEUTIC CHARACTERISTICS OF 4 ONCE-DAILY CONTROLLED-RELEASE DILTIAZEM PREPARATIONS, Fundamental and clinical pharmacology, 12(5), 1998, pp. 559-565
Authors:
PEETERS PAM
VANLIER JJ
VANDEMERBEL N
OOSTERHUIS B
WIELING J
JONKMAN JHG
KLESSING K
BIBER A
Citation: Pam. Peeters et al., PHARMACOKINETICS OF [C-14]-LABELED LOSIGAMONE AND ENANTIOMERS AFTER ORAL-ADMINISTRATION TO HEALTHY-SUBJECTS, European journal of drug metabolism and pharmacokinetics, 23(1), 1998, pp. 45-53
Authors:
WILFFERT B
TAMMINGA WJ
WEMER J
OOSTERHUIS B
WIELING J
JONKMAN JHG
DELEY LFMH
DEZEEUW RA
Citation: B. Wilffert et al., DISTRIBUTION OF CYP2D6 AND CYP2C19 PHENOTYPES IN DUTCH MALE AND FEMALE VOLUNTEERS IN CLINICAL-PHARMACOLOGY STUDIES, Naunyn-Schmiedeberg's archives of pharmacology, 357(4), 1998, pp. 690-690
Authors:
VANDEMERBEL NC
WILKENS G
FOWLES S
OOSTERHUIS B
JONKMAN JHG
Citation: Nc. Vandemerbel et al., LC PHASES IMPROVE, BUT NOT ALL ASSAYS DO - METFORMIN BIOANALYSIS REVISITED, Chromatographia, 47(9-10), 1998, pp. 542-546
Authors:
WIELING J
HENDRIKS G
TAMMINGA WJ
HEMPENIUS J
MENSINK CK
OOSTERHUIS B
JONKMAN JHG
Citation: J. Wieling et al., RATIONAL EXPERIMENTAL-DESIGN FOR BIOANALYTICAL METHODS VALIDATION - ILLUSTRATION USING AN ASSAY-METHOD FOR TOTAL CAPTOPRIL IN PLASMA, Journal of chromatography, 730(1-2), 1996, pp. 381-394
Authors:
OOSTERHUIS B
BRANNAN MD
GROEN H
PEETERS PAM
HEMPENIUS J
RADWANSKI E
NOMEIR AA
AFFRIME MB
JONKMAN JHG
Citation: B. Oosterhuis et al., BIOPHARMACEUTIC CHARACTERISTICS OF A NEW EXTENDED-RELEASE THEOPHYLLINE FORMULATION (UNI-DUR), Annals of allergy, asthma, & immunology, 75(2), 1995, pp. 157-161
Authors:
WETSTEYN JCFM
DEVRIES PJ
OOSTERHUIS B
VANBOXTEL CJ
Citation: Jcfm. Wetsteyn et al., THE PHARMACOKINETICS OF 3 MULTIPLE-DOSE REGIMENS OF CHLOROQUINE - IMPLICATIONS FOR MALARIA CHEMOPROPHYLAXIS, British journal of clinical pharmacology, 39(6), 1995, pp. 696-699
Authors:
STORM G
OOSTERHUIS B
SOLLIE FAE
VISSCHER HW
SOMMER W
BEITINGER H
JONKMAN JHG
Citation: G. Storm et al., LACK OF PHARMACOKINETIC INTERACTION BETWEEN VINPOCETINE AND OXAZEPAM, British journal of clinical pharmacology, 38(2), 1994, pp. 143-146
Authors:
TUININGA YS
CRIJNS HJGM
OOSTERHUIS B
WIESFELD ACP
VANWIJK TM
ALBRONDA F
DEBRUIN ID
JONKMAN JHG
KOZMA C
LIE KI
Citation: Ys. Tuininga et al., HEMODYNAMIC-EFFECTS OF THE NEW ANTIARRHYTHMIC AGENT RESTACORIN IN PATIENTS WITH NORMAL AND DECREASED LEFT-VENTRICULAR FUNCTION, Journal of cardiovascular pharmacology, 23(3), 1994, pp. 408-414
Citation: Pj. Devries et al., SINGLE-DOSE PHARMACOKINETICS OF CHLOROQUINE AND ITS MAIN METABOLITE IN HEALTHY-VOLUNTEERS, Drug investigation, 8(3), 1994, pp. 143-149
Authors:
LELIBOUX A
TEULE M
FRYDMAN A
OOSTERHUIS B
JONKMAN JHG
Citation: A. Leliboux et al., EFFECT OF DIET ON THE SINGLE-DOSE AND MULTIPLE-DOSE PHARMACOKINETICS OF SUSTAINED-RELEASE KETOPROFEN, European Journal of Clinical Pharmacology, 47(4), 1994, pp. 361-366
Citation: B. Oosterhuis et Jhg. Jonkman, PHARMACOKINETIC STUDIES IN HEALTHY-VOLUNTEERS IN THE CONTEXT OF INVITRO INVIVO CORRELATIONS, European journal of drug metabolism and pharmacokinetics, 18(1), 1993, pp. 19-30
Citation: B. Oosterhuis et Jhg. Jonkman, ADVANTAGES AND DISADVANTAGES OF REFORMULATION OF OLDER DRUGS, Clinical pharmacokinetics, 25(3), 1993, pp. 165-171